Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
57 Leser
Artikel bewerten:
(0)

Dr. Robert Lanza Featured on Michio Kaku's 'Explorations in Science' / Eminent theoretical physicist and co-founder of string theory interviews Advanced Cell's Chief Scientist about his research and new book 'Biocentrism'

WORCESTER, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Advanced Cell Technology, Inc., announced today that Dr. Robert Lanza, its Chief Scientific Officer, will be featured this week on "Explorations in Science" with Dr. Michio Kaku, an hour long radio program on science, technology, politics, and the environment. It is broadcast each week on public radio in New York City (WBAI 99.5 FM), and re-aired in Los Angeles, San Francisco, Tampa, Houston, and stations across the country. Explorations can also be heard around the world via the web at http://www.kpfa.org/archive/show/51. The show focuses on Dr. Lanza's research on cloning, stem cells, and his new book "Biocentrism."

Dr. Lanza is also scheduled to appear on Dr. Kaku's commercial radio show "Science Fantastic," which airs in 127 cities around the country, making it the largest nationally syndicated science radio show on commercial radio. The program focuses the future of science. Past featured guests include Nobel laureates and top researchers on the topics of string theory, time travel, black holes, gene therapy, aging, space travel, artificial intelligence and SETI.

Dr. Kaku holds the Henry Semat Chair and Professorship in theoretical physics at City College of New York. He is the co-founder of string field theory, and is currently engaged in defining the "Theory of Everything," which seeks to unify the fundamental forces of the universe. In addition to authoring textbooks on string theory and quantum field theory, Dr. Kaku is also the best- selling author of popular books, such as "Hyperspace," "Beyond Einstein," and "Physics of the Impossible" (which is currently on the New York Times top 10 bestseller list). On his show, Lanza discusses the cutting edge of cloning (including the cloning of endangered/extinct species and cells for medical therapy), as well as the future of regenerative medicine using stem cells to grow organs and to treat human disease.

Drs. Lanza and Kaku also discuss "Biocentrism: How life and consciousness are the keys to understanding the true nature of the universe." "We think life is an accident of physics and chemistry," explains Lanza. "But a long list of experiments suggests just the opposite. Amazingly, if you add life to the equation, you can explain some of the biggest puzzles of science. For instance, it becomes clear why space and time -- and even the properties of matter itself -- depend on the observer. Biocentrism even explains why the laws of the universe are fine-tuned for the existence of life."

Click here for a complete list of stations carrying the show: http://www.mkaku.org/ About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com/.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

Advanced Cell Technology, Inc.

CONTACT: Kathy Singh of Advanced Cell Technology, Inc., +1-508-756-1212,
Ext. 653

Web Site: http://www.advancedcell.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.